Correction: Is the CTS5 a helpful decision-making tool in the extended adjuvant therapy setting?

Breast Cancer Res Treat. 2024 Jul;206(2):441. doi: 10.1007/s10549-024-07351-5.

Kerstin Wimmer^{1

2}, Dominik Hlauschek³, Marija Balic⁴, Georg Pfeiler^{5

6}, Richard Greil^{7

8

9}, Christian F Singer^{5

6}, Stefan Halper¹⁰, Günther Steger¹¹, Christoph Suppan⁴, Simon P Gampenrieder^{7

8

9}, Ruth Helfgott¹², Daniel Egle¹³, Martin Filipits¹⁴, Raimund Jakesz⁵, Lidija Sölkner³, Christian Fesl³, Michael Gnant^{3

5}, Florian Fitzal^{15

5}

¹ Department of General Surgery, Division of Visceral Surgery, Medical University of Vienna, Vienna, Austria. [email protected].
² Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. [email protected].
³ Austrian Breast & Colorectal Cancer Study Group, Vienna, Austria.
⁴ Department of Oncology, Medical University of Graz, Graz, Austria.
⁵ Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
⁶ Department of Gynecology and Obstetrics, Medical University of Vienna, Vienna, Austria.
⁷ Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Paracelsus Medical University Salzburg, Salzburg, Austria.
⁸ Salzburg Cancer Research Institute-CCCIT, Salzburg, Austria.
⁹ Cancer Cluster Salzburg, Salzburg, Austria.
¹⁰ Department of Surgery, Regional Hospital Wiener Neustadt, Wiener Neustadt, Austria.
¹¹ Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria.
¹² Department of Surgery, Ordensklinikum Linz - Sisters of Charity, Linz, Austria.
¹³ Department of Gynaecology, Medical University Innsbruck, Innsbruck, Austria.
¹⁴ Center for Cancer Research, Medical University of Vienna, Vienna, Austria.
¹⁵ Department of General Surgery, Division of Visceral Surgery, Medical University of Vienna, Vienna, Austria.

No abstract available

Publication types